MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Cognition in parkinson disease: Tunisian clinical experience

    F. Syrine, B. Nadia, H. Hela, F. Saloua, B. Mariem, FRE. Mohamed (tunis, Tunisia)

    Objective: In this study, we identified among Parkinson Disease patients those pre-disposed to cognitive impairment, and described their clinical profiles. Background: Parkinson disease (PD) is…
  • 2022 International Congress

    Progressive ataxia and palatal tremor due to a novel heterozygous GRIN2A mutation

    E. Ardila, G. Kägi, F. Brugger (St. Gallen, Switzerland)

    Objective: Describe the case of a patient with adult-onset progressive ataxia and palatal tremor (PAPT) in association with a novel heterozygous mutation of the GRIN2A…
  • 2022 International Congress

    High frequency neck vibration changes the pallidal activity in cervical dystonia

    A. Sedov, A. Gamaleya, U. Semenova, S. Usova, R. Medvednik, A. Tomskiy, H. Jinnah, A. Shaikh (Moscow, Russian Federation)

    Objective: The aim of the current study is to characterize changes in spontaneous pallidal neuronal activity during modulation of peripheral proprioceptive input by means of…
  • 2022 International Congress

    Deep learning to distinguish Parkinson’s from controls in video, without human-defined measures

    J. Yang, S. Williams, D. Hogg, J. Alty, S. Relton ()

    Objective: We aimed to apply a deep learning neural network directly to video of finger tapping, without human-defined measures or features, for a computer to…
  • 2022 International Congress

    Gold and silver nanoparticle-based Localized Surface Plasmon Resonance Sensor (LSPR) for the detection of histidine as a potential biomarker in Parkinson’s Disease.

    E. Robles, C. Acevedo-Castillo, D. Martínez-Ramírez (Monterrey, Mexico)

    Objective: Previous literature has proven that histamine has a crucial role in the process of neuroinflammation in Parkinson's Disease (PD) . We can indirectly detect…
  • 2022 International Congress

    Alpha-synuclein fibril-based mouse model of REM sleep behavior disorder as a prodrome of synucleinopathy

    HS. Yoo, R. Luke, C. Durso, Y. Liang, J. Steltz, D. Chernoff, B. Zhang, KH. Hoxha, B. Dugan, JJ. Fraigne, W. O’Brien, J. Peever, K. Luk (Seoul, Republic of Korea)

    Objective: To investigate whether in wild-type mice, inoculation of α-synuclein (aSyn) preformed fibrils (PFFs) into the sublaterodorsal tegmental nucleus (SLD), a core structure associated with…
  • 2022 International Congress

    Longitudinal Analysis of the Corticospinal Tract in Parkinson’s disease Patients

    R. Guimaraes, L. Ramalho, B. Campos, F. Cendes (Campinas, Brazil)

    Objective: To assess longitudinal diffusion tensor imaging differences between PD patients in 8 corticospinal tract segments. Background: Parkinson’s disease (PD) is clinically defined by the presence…
  • 2022 International Congress

    Olfactory dysfunction in patients with Huntington disease

    J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…
  • 2022 International Congress

    Incidental Lewy Body disease and idiopathic Parkinson’s disease: from common pathogenic factors to the overlapping clinical features

    E. Sansa, T. Warner, E. Depablo Fernandez (London, United Kingdom)

    Objective: To compare established early symptoms and risk factors associated with Parkinson’s disease (PD) in a cohort of incidental Lewy Body disease (iLBD) and healthy…
  • 2022 International Congress

    Effects of Once-Daily Opicapone 50 mg on COMT activity: A Pooled Post-hoc Analysis of Two Phase 1 Studies

    G. Loewen, A. Vijan, K. Olson, T. O'Reilly, G. Liang, O. Klepitskaya (San Dieg, USA)

    Objective: To assess the effects of opicapone (OPC) 50 mg adjunct to carbidopa/levodopa (CD/LD) on catechol-O-methyltransferase (COMT) activity by participants’ baseline characteristics using pooled data…
  • « Previous Page
  • 1
  • …
  • 816
  • 817
  • 818
  • 819
  • 820
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley